Overview

Price Delayed by 20 minutes

Alimera is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharmaceuticals. Alimera is presently focused on diseases affecting the back of the eye, or retina, because these diseases are not well treated with current therapies and affect millions of people in our aging populations.

Tear Sheet IR Contacts Subscribe to News Alerts RSS Feed

Company Profile

6120 Windward Parkway, Suite 290
Alpharetta, GA 30005

1 (844) 445-8843

(678) 990 5744

info@alimerasciences.com

Leadership

View Management Team

Recent News & Filings

News

View All News Articles

Filings

View All Filings

Alimera Sciences New Day Trial Initiation Presentation

Alimera Sciences New Day Study Webcast

Corporate Presentation

Quarterly Report

Investor Relations

Cindy Rizzo, CORE IR
516 222 2560
ir@alimerasciences.com

Transfer Agent

AST Financial, Bryan Anderson,
Relationship Manager
banderson@astfinancial.com

Auditors

Grant Thornton LLP
Joseph Heatherly, Partner,
Joseph.Heatherly@us.gt.com

Corporate Counsel

Charles Vaughn,
Nelson Mullins
(404) 322-6189
charles.vaughn@nelsonmullins.com